89 related articles for article (PubMed ID: 34598060)
1. GUEST EDITORIAL: Theranostics in breast cancer-a vision.
Biersack HJ; Höffken K
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14473-14474. PubMed ID: 37548771
[No Abstract] [Full Text] [Related]
2. Leveraging epitranscriptomics for cardiovascular disease theranostics.
Sopic M; Stopa V; Devaux Y
Eur Heart J; 2024 Apr; 45(13):1098-1100. PubMed ID: 38190430
[No Abstract] [Full Text] [Related]
3. The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment.
Ferreira-Gonçalves T; Gaspar MM; Coelho JMP; Marques V; Viana AS; Ascensão L; Carvalho L; Rodrigues CMP; Ferreira HA; Ferreira D; Reis CP
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053219
[TBL] [Abstract][Full Text] [Related]
4. Scaffolding along nucleic acid duplexes using 2'-amino-locked nucleic acids.
Astakhova IK; Wengel J
Acc Chem Res; 2014 Jun; 47(6):1768-77. PubMed ID: 24749544
[TBL] [Abstract][Full Text] [Related]
5. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
Campbell MA; Wengel J
Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
[TBL] [Abstract][Full Text] [Related]
6. Prioritising breast cancer theranostics: A current medical longing in oncology.
Pandey PN; Saini N; Sapre N; Kulkarni DA; Tiwari DAK
Cancer Treat Res Commun; 2021; 29():100465. PubMed ID: 34598060
[TBL] [Abstract][Full Text] [Related]
7. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
8. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.
Patel SK; Janjic JM
Theranostics; 2015; 5(2):150-72. PubMed ID: 25553105
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).
Pradeep P; Kumar P; Choonara YE; Pillay V
Expert Opin Ther Pat; 2017 Sep; 27(9):1005-1019. PubMed ID: 28621571
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
